Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking

Author:

Zhang Weitong,Tian Wangqi,Wang Yifan,Jin Xiaojie,Guo Hui,Wang YuweiORCID,Tang Yuping,Yao Xiaojun

Funder

Shaanxi University of Chinese Medicine

National Natural Science Foundation of China

Natural Science Foundation of Shaanxi Province

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference55 articles.

1. The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer;Asamura;J. Thorac. Oncol. off. publ. Int. Assoc. Stud. Lung Cancer,2015

2. Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer;Liu;Clin. Transl. Med.,2017

3. Genome-wide association study of survival in early-stage non-small cell lung cancer;Tang;Ann. Surg. Oncol.,2015

4. Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials;Doria-Rose;Clin. Trials,2010

5. The contribution of “Nanjing” to the theory of traditional Chinese medicine;Hu Jianpeng;Clin. J. Tradit. Chin. Med.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3